Yangling is engaged in non-inositol plant extracts and trading businesses. Its strategy is to focus its production and sales primarily on bilberry. It also acts as a sales agent for a portion of Haizi’s inositol.

Yangling and Lansen’s plant extract division (“Zhiti”) have collaborated closely and established a position as market leaders in bilberry, gingko extract, and ginseng extract. With the completion of Yangling’s multi-function workshop and synthesis workshop for plant extracts expected in 2015, the Group will further expand its product portfolio leveraging on Yangling’s production expertise and Lansen Zhiti’s market access and R&D capabilities.